|
Patients
|
linear trend χ2 test
|
−2 log likelihood
|
P-value
|
|---|
|
All patients (n = 150)
| | | |
|
GPS
|
53.761
|
588.797
|
<0.0001
|
|
mGPS
|
46.707
|
601.175
|
<0.0001
|
|
CLIP
|
109.309
|
545.36
|
<0.0001
|
|
JIS
|
64.461
|
570.82
|
<0.0001
|
|
BCLC
|
61.89
|
577.75
|
<0.0001
|
|
TNM
|
41.6
|
589.84
|
<0.0001
|
|
Curative treatment group (n = 77)
| | | |
|
GPS
|
16.33
|
169.300
|
<0.0001
|
|
mGPS
|
5.07
|
177.93
|
0.03
|
|
CLIP
|
11.28
|
171.76
|
0
|
|
JIS
|
9.68
|
172.22
|
0
|
|
BCLC
|
N/O
|
N/O
|
0.08
|
|
TNM
|
N/O
|
N/O
|
0.09
|
|
Non-curative treatment group (n = 73)
| | | |
|
GPS
|
23.71
|
322.27
|
<0.0001
|
|
mGPS
|
28.815
|
322.579
|
<0.0001
|
|
CLIP
|
29.480
|
311.68
|
<0.0001
|
|
JIS
|
16.72
|
326.370
|
<0.0001
|
|
BCLC
|
20.98
|
321.9
|
<0.0001
|
|
TNM
|
16.42
|
326.7
|
<0.0001
|
- Abbreviations: GPS = Glasgow Prognostic Score; mGPS = modified Glasgow Prognostic Score;
- CLIP = the Cancer of the Liver Italian Program; JIS = the Japan Integrated Staging score;
- BCLC = the Barcelona Clinic Liver Cancer; TNM = tumor nodes metastasis classification; N/O = not obtained.
